Buildings 5B, 26, 53C Air Handling Units (AHU) Replacement
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
FDA OFFICE OF ACQ GRANT SVCS
Contract Value
Not provided
Codes & Classification
Solicitation Number
OC-2026-132850
NAICS
236220 - Commercial and Institutional Building Construction
Classification Code
Z2PZ
Additional Details
Documents1
The U.S. Food and Drug Administration (FDA), through its Office of Facilities Engineering and Mission Support Services (OFEMS), is conducting market research to identify qualified sources for the replacement of air handling units (AHUs) in Buildings 5B, 26, and 53C at the Jefferson Lab Campus, located at the National Center of Toxicological Research (NCTR), 3900 NCTR Road, Jefferson, Arkansas. This notice, issued under procurement identifier OC-2026-132850, is a Sources Sought announcement intended solely for market research purposes and does not constitute a solicitation or request for proposals.
Purpose and Scope:
The primary objective of this procurement is to replace the existing HVAC air handling units in the specified buildings, which have exceeded their useful life, to ensure continued reliable and efficient operation of the campus facilities. The scope of work includes the complete demolition and removal of existing AHUs, associated electrical systems, controls, duct transitions, and piping packages, followed by the installation of new AHUs and, where applicable, heat recovery units. The project also requires the extension of equipment pads as needed and the integration of new HVAC controls into the campus Energy Management System (EMS).
Key Requirements and Deliverables:
- For Building 5B: Demolition of existing air handlers and related systems; installation of new AHUs with all necessary connections; extension of equipment pads; and integration of new HVAC controls with the campus EMS.
- For Building 26: A phased replacement approach due to limited mechanical room space, requiring two of three units to be offline during installation while maintaining operation of one unit; installation of new HVAC controls integrated with the EMS.
- For Building 53C: Demolition and replacement of both the AHU and heat recovery unit, including all associated systems; extension of equipment pads; and integration of new controls with the EMS.
The anticipated period of performance is 48 months from notice to proceed, with an estimated project magnitude between $25 million and $32 million.
Contracting Entity and Classification:
The contracting activity is managed by the FDA Office of Acquisition and Grant Services, a federal office under the Department of Health and Human Services. The associated NAICS code is 236220 (Commercial and Institutional Building Construction), with a small business size standard of $45 million. The Product Service Code is Z2PZ.
Procurement Type and Special Considerations:
This notice is for market research only and is not a solicitation. The FDA seeks capability statements from all business types, including small businesses, to assess industry capacity and inform potential set-aside decisions for small business participation. Respondents are required to provide detailed corporate profiles, evidence of relevant experience and bonding capacity, past performance references for similar projects, and information on performance and customer satisfaction measures. Small businesses must demonstrate compliance with FAR 52.219-14 (Limitations on Subcontracting), while large businesses should identify subcontracting opportunities for small business concerns. The anticipated contract will be subject to FAR Clause 52.225-11 (Buy American—Construction Materials under Trade Agreements).
Submission Instructions and Contact Information:
Interested parties must submit capability statements by email to Nick Sartain at [email protected] by 1:00 pm Central Time on February 27, 2026, referencing OC-2026-132850. Submissions should not exceed 15 pages and must not include proprietary or confidential information. The government will use the information received to refine its requirements and determine the appropriate acquisition strategy but will not provide feedback or acknowledge receipt of individual responses.
This market research effort will help the FDA determine whether to set aside the requirement for small businesses, pursue full and open competition, or consider sole-source acquisition procedures. The government reserves the right to use non-proprietary technical information provided in responses for any future solicitation development.
For further details, interested contractors may refer to the official notice at: https://sam.gov/opp/f4f1fab207ae49e3aa319a784f1b6f32/view
Primary Contact:
Nick Sartain
Email: [email protected]
Phone: 870-543-7370
This opportunity represents a significant construction and modernization effort at a critical FDA research facility, with long-term operational and compliance implications for the selected contractor.